stella
beta
Multicenter Trial of ESK981 in Patients With Select Solid Tumors — Stella
Recruiting
Back to Pancreatic Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
Rogel Cancer Center, Ann Arbor, Michigan
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
View full record on ClinicalTrials.gov